Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans.
about
Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISAAntiretroviral prophylaxis for HIV prevention in heterosexual men and womenFactors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behaviorRelatively low HIV infection rates in rural Uganda, but with high potential for a rise: a cohort study in Kayunga District, UgandaSeroprevalence and factors associated with herpes simplex virus type 2 among HIV-negative high-risk men who have sex with men from Rio de Janeiro, Brazil: a cross-sectional studyPerformance of HSV-2 type specific serological tests in men in Kenya.Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the United StatesComparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.Risk Factors for HSV-2 Infection among Sexual Partners of HSV-2/HIV-1 Co-Infected Persons.Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couplesSensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban UgandansMature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countriesHerpes simplex virus type 2 seroprevalence and incidence in acute and chronic HIV-1 infectionPerformance of the BioPlex 2200 multiplexing immunoassay platform for the detection of herpes simplex virus type 2 specific antibodies in African settings.Sero-prevalence of herpes simplex type 2 virus (HSV-2) and HIV infection in Kampala, Uganda.Prevalence and incidence estimation of HSV-2 by two IgG ELISA methods among South African women at high risk of HIV.High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trialEvaluating HIV Prevention Programs: Herpes Simplex Virus Type 2 Antibodies as Biomarker for Sexual Risk Behavior in Young Adults in Resource-Poor Countries.Performance of the Euroline Western blot assay in the detection of herpes simplex virus type 2 antibody in Uganda, China and the USA.Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessmentGlobal Diversity within and between Human Herpesvirus 1 and 2 Glycoproteins.Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial.Effect of sexually transmitted disease (STD) coinfections on performance of three commercially available immunosorbent assays used for detection of herpes simplex virus type 2-specific antibody in men attending Baltimore, Maryland, STD clinics.Use of commercial enzyme immunoassays to detect antibodies to the herpes simplex virus type 2 glycoprotein G in a low-risk population in Hanoi, Vietnam.Clinical assessment of assays for diagnosis of herpes simplex infection.Herpes simplex virus type 2: epidemiology and management options in developing countries.Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.The epidemiology of herpes simplex virus type-2 infection among married women in Mysore, India.Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2.Interactions and management issues in HSV and HIV coinfection.Comparison of three commercial immunoassays for detection of herpes simplex virus type 2 antibodies in commercial sex workers in Yunnan Province, China.The diagnosis of genital herpes - beyond culture: An evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology.Gender differences in the prevalence of sexually transmitted infections and genital symptoms in an urban setting in southern India.Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy.Performance of focus ELISA tests for HSV-1 and HSV-2 antibodies among university students with no history of genital herpes.Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trialIncident HSV-2 infections are common among HIV-1-discordant couples.
P2860
Q24812650-026FEEA4-2BD0-4BFB-83CC-BE6561686D22Q28270788-058D3CB5-39FB-4F4F-9CD9-59B2C5DB1459Q28741365-A1AEF1D1-02F0-4959-AC89-5ED0324A7D60Q33398034-9A735419-4DA2-493B-832D-52C5ACE014D9Q33425027-7A804105-F38E-44AF-95E7-FAB2CAD461AFQ33646202-0A15D250-A3DB-439B-B32E-DC14610D67B0Q33801040-6B375A64-85BC-4025-B626-046F93FE63EFQ33813876-4AB09225-C6D7-48B4-B227-797DF62A048BQ33835357-43AE068A-EE16-4EE4-8ABE-F43D0161F158Q33846603-958375B9-20B5-4E5E-BB1E-AA09912A0D6FQ33881449-7B6B4E2C-A82D-4190-8939-8116C621B351Q34058693-4D403B9A-1154-4D5C-9ACA-649F61B624F3Q34670442-86BA55D5-79C0-472E-B4E4-A747B6C131B9Q34720324-8DE114B4-7BF6-4895-8347-BCF48CEEE799Q34734012-50EFECF4-1A5B-41F1-B838-7E14C0CAA961Q35038122-8F12E716-E3EA-4AD6-A9E0-A13C06C13CD3Q35138634-BBD12132-835D-4A8D-839C-EF9A1DC19724Q35207119-804ABC7C-7F57-42B2-9AA2-29BE9A2CE92DQ35209414-25722CA1-B543-425E-9FD9-3E12DDC9F289Q35639207-3A198520-ABCB-4BA3-BE51-221EBEB75091Q35641538-623D9B15-9F69-45E4-93EC-7109CA974317Q35683057-84168876-8BAB-4F39-851A-EBAD3705AF3DQ35794339-C12C651F-4141-495E-A68B-9D1B788EC1DCQ35914319-E8B505A3-4F6A-4875-B722-4863E80C715BQ36167250-A3DA1BB8-852A-4D5D-898B-F10E9AEBF7C5Q36314074-10F99034-E82C-4D2A-91CB-2FB417C13684Q36452397-6ED8C465-7E62-478A-A59A-0CE633BE312AQ36607303-16211ACB-F49B-4552-BC01-AC413317B746Q36650973-9D6A96C8-8B40-4BAB-BD5A-225753117C1FQ36672554-4D50EBE7-1D59-4B94-B51C-6928B4C2556EQ36731872-0907A779-F99D-445E-86E2-06A95C682D59Q36747513-D971A9C6-ABFC-4C79-958F-65BFCACF282CQ36777844-5547AF22-E9DE-4E07-8053-F5D8DA1D4FDFQ36844905-94540BE4-0189-4229-81E8-BE63E01C4F20Q36871260-B1733DDD-E945-4051-B71D-C3B4528AE77CQ36928704-4E5558A2-F4E9-4091-9E57-BC64BA4AA3CAQ37070372-AD198003-5C9B-424F-BEA7-19C8D8242F5BQ37110895-37A67B5B-CE95-4AA3-9869-7218433D0383Q37114698-42794E74-9ACE-4DAE-90F2-27E86D67973FQ37145745-68D92F8D-B9CE-4BD4-952C-E7DD78D1E7B4
P2860
Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Performance of a commercial, t ...... ecific antibodies in Ugandans.
@en
Performance of a commercial, t ...... ecific antibodies in Ugandans.
@nl
type
label
Performance of a commercial, t ...... ecific antibodies in Ugandans.
@en
Performance of a commercial, t ...... ecific antibodies in Ugandans.
@nl
prefLabel
Performance of a commercial, t ...... ecific antibodies in Ugandans.
@en
Performance of a commercial, t ...... ecific antibodies in Ugandans.
@nl
P2093
P2860
P50
P1476
Performance of a commercial, t ...... ecific antibodies in Ugandans.
@en
P2093
Bobbi Jo Horne
Charla Henson
Ruby H-N Nguyen
Wayne Hogrefe
P2860
P304
P356
10.1128/JCM.42.4.1794-1796.2004
P407
P50
P577
2004-04-01T00:00:00Z